Treatment & Doctors
FDA Approves Keytruda for Certain Mesothelioma Patients
- by Tim Povtak
- Treatment & Doctors
- Jun 17, 2020
Patients with pleural mesothelioma cancer may have another treatment option after the U.S. Food and Drug Administration approved the use of pembrolizumab for certain metastatic tumors this week. Pembrolizumab,…
Read More
Mesothelioma Specialist Brings HIPEC Expertise to Stanford
- by Tim Povtak
- Treatment & Doctors
- May 26, 2020
Surgical oncologist and mesothelioma specialist Dr. Byrne Lee spent close to a decade in Southern California, building a well-respected peritoneal surface malignancy program at City of Hope Comprehensive Cancer…
Read More
UK Oncologist Proposes Novel Treatment for Mesothelioma
- by Tim Povtak
- Treatment & Doctors
- Apr 22, 2020
Medical oncologist Dr. Angus Dalgleish never did like standard of care treatment for pleural mesothelioma cancer, even when he reluctantly recommended it in the past. He believes now there…
Read More
Duke Study Challenges Mesothelioma Chemotherapy Practices
- by Tim Povtak
- Treatment & Doctors
- Apr 16, 2020
Neoadjuvant chemotherapy — often used before aggressive surgery — has shown no definitive survival benefit for patients with pleural mesothelioma cancer, according to a recent study at the Duke University…
Read More
Mesothelioma Survivors Face Critical COVID-19 Challenges
- by Fran Mannino
- Treatment & Doctors
- Mar 26, 2020
As the U.S. comes to grips with the challenges of the COVID-19 pandemic, mesothelioma cancer survivors face additional hurdles, including difficulty receiving care. Patients currently undergoing…
Read More
Coronavirus Postpones Mesothelioma Symposium
- by Tim Povtak
- Treatment & Doctors
- Mar 5, 2020
The Mesothelioma Applied Research Foundation has postponed its annual International Symposium on Malignant Mesothelioma next month because of the COVID-19 virus, commonly known as the novel coronavirus. The…
Read More
Mesothelioma Detection May Come Earlier with Liquid Biopsy
- by Tim Povtak
- Treatment & Doctors
- Feb 18, 2020
Cellular Analytics, a biotechnology company in Ontario, Canada, has unveiled a novel liquid biopsy test for mesothelioma that could lead to more effective management of this rare cancer.
Read More
Alternative to Alimta Coming for Mesothelioma Patients
- by Tim Povtak
- Treatment & Doctors
- Feb 12, 2020
The U.S. Food and Drug Administration has granted final approval of Pemfexy, a new brand of the chemotherapy drug pemetrexed, to combat malignant mesothelioma and advanced stage non-small…
Read More
Comparative Study Reveals Best Mesothelioma Surgery
- by Tim Povtak
- Treatment & Doctors
- Dec 5, 2019
Less is usually better than more when it comes to aggressive surgery for pleural mesothelioma, according to the latest and most-extensive comparative study. Throughout the last 25 years, surgical…
Read More
DaSilva Building Mesothelioma Specialty Program in Orlando
- by Tim Povtak
- Treatment & Doctors
- Dec 3, 2019
Thoracic surgeon Dr. Marcelo DaSilva came to Orlando, Florida, with a lofty goal. He wants to make Central Florida a destination for patients diagnosed with malignant pleural mesothelioma. DaSilva…
Read More
